Medical Device Industry News

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Covidien says it plans to divest its some of its vascular therapies business to mollify U.S. anti-trust regulators about its proposed $43 billion merger with Medtronic.

Covidien plans to sell some vascular therapies ahead of Medtronic merger

MassDevice.com +3 | The top 3 medtech stories for October 24, 2014

October 24, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtech's betting on the GOP in midterm elections

October 24, 2014 by Brian Johnson

A look at the top 10 politicial action committee donations shows that medtech is betting heavily on a GOP win in the midterm elections.

Medtech's betting on the GOP in midterm elections

The medical device industry is betting on a Republican sweep of the U.S. Congress during the 2014 mid term elections, according to a MassDevice.com analysis of donations made by the industry's 10 largest political action committees.

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic issues an update on the debt financing behind its pending $43 billion acquisition of Covidien.

Medtronic updates on $43B Covidien deal financing

Novo Nordisk receives U.S. subpoena related to Danish factory

October 24, 2014 by MassDevice

The U.S. attorney for Massachusetts subpoenas Novo Nordisk for documents on its plant in Denmark that makes half the world's supply of insulin.

Novo Nordisk receives U.S. subpoena related to Danish factory

(Reuters) - Denmark's Novo Nordisk , the world's biggest maker of insulin, has received a U.S. subpoena requesting documents relating to potential manufacturing issues at its Kalundborg plant in Denmark, the company said on Friday.

Sinopsys Surgical gains $8.3M funding round for sinusitis device | Medtech funding for the week of October 20, 2014

October 24, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Sinopsys Surgical sniffs up $8.3m for sinusitis device; ZipLine Medical adds $5.7m to Series C round; Medrobotics taps backers for $20m; Sensory Medical raises $1.4m for Relaxis restless legs treatment; Stealth hypertension startup Sympara Medical raises nearly $6m

Sinopsys Surgical sniffs up $8.3m for sinusitis device

October 17, 2014 by Alexander Soule

Report: EndoStim tables IPO

October 24, 2014 by Brad Perriello

EndoStim, which makes an implantable device to treat gastroesophageal reflux disease, reportedly tables its initial public offering due to poor market conditions.

Report: EndoStim tables IPO

EndoStim, citing poor market conditions, has tabled its initial public offering it hoped would raise nearly $36 million for its neurostimulation device for gastroesophageal reflux disease, according to Renaissance Capital.

EndoStim had planned to put $10 million of the IPO's proceeds into clinical studies and another $14 million to commercialize the system.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp